Case number 2017-1947
Anacor Pharmaceuticals, Inc. v. Iancu > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ANACOR PHARMACEUTICALS, INC. v. IANCU [OPINION] [precedential] (0) |
| Jul 5, 2018 | 56 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [533655] [JAB] [Entered: 07/05/2018 09:41 AM] (0) |
| May 14, 2018 | 55 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Reyna, Circuit Judge; Bryson, Circuit Judge and Stoll, Circuit Judge). [521318] [JAB] [Entered: 05/14/2018 10:39 AM] (0) |
| Apr 5, 2018 | 53 | Submitted after ORAL ARGUMENT by Michael N. Kennedy for Anacor Pharmaceuticals, Inc. and Sarah E. Craven for Iancu. Panel: Judge: Reyna , Judge: Bryson , Judge: Stoll. [510832] [JAB] [Entered: 04/05/2018 11:13 AM] (0) |
| Mar 12, 2018 | 52 | 6 paper copies of the Joint Appendix [36] received from Appellant Anacor Pharmaceuticals, Inc. [504175] [SJL] [Entered: 03/12/2018 12:53 PM] (0) |
| Mar 8, 2018 | 51 | Response to oral argument order from the Intervenor Iancu. designating Sarah E. Craven as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [503446] [Sarah Craven] [Entered: 03/08/2018 09:46 AM] (0) |
| Mar 7, 2018 | 49 | Clerk's Note to the File: The court requests six additional paper copies of the Joint Appendix [36]. Not all pages in the paper copies received on 10/10/2017 contain Appx numbers. Please provide corrected paper copies by 03/14/2018. [503183] [JAB] [Entered: 03/07/2018 12:09 PM] (0) |
| Mar 7, 2018 | 50 | Response to oral argument order from the Appellant Anacor Pharmaceuticals, Inc.. designating Michael N. Kennedy as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [503379] [Michael Kennedy] [Entered: 03/07/2018 06:14 PM] (0) |
| Feb 21, 2018 | 48 | NOTICE OF CALENDARING. Panel: 1804L. Case scheduled Apr 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 03/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [499756] [JAB] [Entered: 02/21/2018 01:04 PM] (0) |
| Feb 8, 2018 | 47 | Official caption revised to reflect substitution of Andrei Iancu, Director, U.S. Patent and Trademark Office as Appellee. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [496354] [CMP] [Entered: 02/08/2018 02:15 PM] (0) |
| Oct 31, 2017 | 46 | Notice from Appellant Anacor Pharmaceuticals, Inc. regarding conflicts with oral argument (unavailable Jan. 8-12, 2018; Mar. 12, 2018; Apr. 2, 2018; Apr. 30-May 4, 2018; Jun. 4-8, 2018). Service: 10/31/2017 by email. [471977] [Michael Kennedy] [Entered: 10/31/2017 02:48 PM] (0) |
| Oct 25, 2017 | 45 | Notice from Intervenor Joseph Matal regarding conflicts with oral argument (unavailable between June 4-6, 2018). Service: 10/25/2017 by email. [470509] [Sarah Craven] [Entered: 10/25/2017 02:47 PM] (2) |
| Oct 25, 2017 | 44 | 6 paper copies of the Amicus Brief [39] received from Amicus Curiae FlatWing Pharmaceuticals, LLC. [470452] [CW] [Entered: 10/25/2017 12:26 PM] (0) |
| Oct 25, 2017 | 43 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks (January 2018, February 2018, March 2018), or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 11/01/2017. [470327] [JCA] [Entered: 10/25/2017 09:21 AM] (0) |
| Oct 24, 2017 | 42 | CORRECTED certificate of service for Amicus Curiae FlatWing Pharmaceuticals, LLC for certificate of interest , Doc No. [41]. Service: 10/21/2017 by email. [470222] [James Carmichael] [Entered: 10/24/2017 04:58 PM] (1) |
| Oct 23, 2017 | 41 | Certificate of Interest for the Amicus Curiae FlatWing Pharmaceuticals, LLC. Service: 10/21/2017 by email. [469619] [James Carmichael] [Entered: 10/21/2017 05:07 PM] (2) |
| Oct 20, 2017 | 40 | Clerk's Note to the File: Certificate of Interest for Amicus Curiae FlatWing Pharmaceuticals, LLC is due on 11/03/2017. [469360] [CMP] [Entered: 10/20/2017 11:46 AM] (0) |
| Oct 20, 2017 | 39 | AMICUS BRIEF FILED for FlatWing Pharmaceuticals, LLC [27]. Number of Pages: 10. Service: 09/20/2017 by email. The paper copies of the brief should be received by the court on or before 10/27/2017. [469357] [CMP] [Entered: 10/20/2017 11:41 AM] (15) |
| Oct 19, 2017 | 38 | ORDER filed. The motion [26] is granted. Service: 10/19/2017 by clerk. [469235] [LMS] [Entered: 10/19/2017 04:24 PM] (2) |
| Oct 10, 2017 | 37 | 6 paper copies of the Joint Appendix [36] received from Appellant Anacor Pharmaceuticals, Inc. [466571] [CW] [Entered: 10/10/2017 03:15 PM] (0) |
| Oct 4, 2017 | 36 | APPENDIX FILED for Anacor Pharmaceuticals, Inc. [35]. Number of Pages: 545. Service: 10/04/2017 by email. The paper copies of the brief should be received by the court on or before 10/12/2017. [465660] [CMP] [Entered: 10/04/2017 04:31 PM] (545) |
| Oct 4, 2017 | 35 | TENDERED from Appellant Anacor Pharmaceuticals, Inc.. Title: JOINT APPENDIX. Service: 10/04/2017 by email. [465555] [Michael Kennedy] [Entered: 10/04/2017 02:26 PM] (545) |
| Oct 3, 2017 | 34 | 6 paper copies of the Reply Brief [30] received from Appellant Anacor Pharmaceuticals, Inc. [465262] [JCP] [Entered: 10/03/2017 03:45 PM] (0) |
| Oct 3, 2017 | 33 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The certificate of interest included with the reply [32] is incomplete as to updated form 9 question #5. CORRECTION: Please ensure future filings comply with recently amended FCR 47.4 and 47.5. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [464961] [CMP] [Entered: 10/03/2017 09:31 AM] (0) |
| Oct 2, 2017 | 32 | REPLY of FlatWing Pharmaceuticals, LLC, as amicus to response filed by Appellant in 17-1947 , Doc. No [31]. Service: 10/02/2017 by email. [464913] [James Carmichael] [Entered: 10/02/2017 06:05 PM] (12) |
| Sep 28, 2017 | 31 | RESPONSE of Appellant Anacor Pharmaceuticals, Inc. to the motion for leave to file an amicus curiae brief [26]. Service: 09/28/2017 by email. [464046] [Michael Kennedy] [Entered: 09/28/2017 12:40 PM] (8) |
| Sep 27, 2017 | 30 | REPLY BRIEF FILED for Appellant Anacor Pharmaceuticals, Inc. [29]. Number of Pages: 27. Service: 09/27/2017 by email. The paper copies of the brief should be received by the court on or before 10/04/2017. Appendix is due 10/04/2017. [463876] [CMP] [Entered: 09/27/2017 03:44 PM] (35) |
| Sep 27, 2017 | 29 | TENDERED from Appellant Anacor Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 09/27/2017 by email. [463852] [Michael Kennedy] [Entered: 09/27/2017 02:29 PM] (35) |
| Sep 21, 2017 | 28 | ORDER filed. Any opposition to the motion [26] shall be filed no later than seven days from the date of issuance of this order. Any reply is due no later than three days from the filing of the response. Service: 09/21/2017 by clerk. [462846] [LMS] [Entered: 09/21/2017 03:56 PM] (2) |
| Sep 20, 2017 | 25 | Entry of appearance for James T. Carmichael as principal counsel for FlatWing Pharmaceuticals, Inc. as amicus. Service: 09/20/2017 by email. [462392] [James Carmichael] [Entered: 09/20/2017 01:58 PM] (1) |
| Sep 20, 2017 | 26 | MOTION of FlatWing Pharmaceuticals, LLC as amicus for leave to file an amicus curiae brief. Any response is due within 10 days of service [Consent: opposed]. Service: 09/20/2017 by email. [462532] [James Carmichael] [Entered: 09/20/2017 05:10 PM] (7) |
| Sep 20, 2017 | 27 | TENDERED from FlatWing Pharmaceuticals, LLC Title: RESPONSE BRIEF. Service: 09/20/2017 by email. [462534] [James Carmichael] [Entered: 09/20/2017 05:14 PM] (15) |
| Sep 18, 2017 | 24 | 6 paper copies of the Intervenor Brief [23] received from Intervenor Joseph Matal. [461724] [CW] [Entered: 09/18/2017 12:47 PM] (0) |
| Sep 13, 2017 | 22 | TENDERED from Intervenor Joseph Matal. Title: INTERVENOR BRIEF. Service: 09/13/2017 by email. [460698] [Sarah Craven] [Entered: 09/13/2017 01:44 PM] (50) |
| Sep 13, 2017 | 23 | BRIEF FILED for Intervenor Joseph Matal [22]. Number of Pages: 39. Service: 09/13/2017 by email. The paper copies of the brief should be received by the court on or before 09/20/2017. Appellant Anacor Pharmaceuticals, Inc. reply brief is due 09/27/2017. [460797]--[Edited 09/21/2017 by clerk to correct docket text] [JCA] [Entered: 09/13/2017 04:17 PM] (50) |
| Aug 21, 2017 | 21 | Entry of appearance for Lore A. Unt as of counsel for Intervenor Joseph Matal. Service: 08/21/2017 by email. [455407] [Lore Unt] [Entered: 08/21/2017 01:36 PM] (2) |
| Aug 10, 2017 | 20 | 6 paper copies of the Opening Brief [19] received from Appellant Anacor Pharmaceuticals, Inc. [452976] [CW] [Entered: 08/10/2017 11:34 AM] (0) |
| Aug 4, 2017 | 19 | BRIEF FILED for Appellant Anacor Pharmaceuticals, Inc. [18]. Number of Pages: 51. Service: 08/04/2017 by email. The paper copies of the brief should be received by the court on or before 08/15/2017. Intervenor brief is due 09/13/2017. [452096] [JCA] [Entered: 08/08/2017 11:30 AM] (156) |
| Aug 4, 2017 | 18 | TENDERED from Appellant Anacor Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 08/04/2017 by email. [451587] [Michael Kennedy] [Entered: 08/04/2017 02:10 PM] (156) |
| Jul 28, 2017 | 17 | Entry of appearance for Evan S. Krygowski as of counsel for Appellant Anacor Pharmaceuticals, Inc.. Service: 07/28/2017 by email. [450107] [Evan Krygowski] [Entered: 07/28/2017 03:03 PM] (2) |
| Jul 6, 2017 | 16 | Docketing Statement for the Intervenor Joseph Matal. Service: 07/06/2017 by email. [444530] [Sarah Craven] [Entered: 07/06/2017 02:35 PM] (3) |
| Jun 30, 2017 | 15 | Clerk's Note to the File: Docketing Statement for Intervenor is due 07/31/2017. [443548] [CMP] [Entered: 06/30/2017 02:37 PM] (0) |
| Jun 30, 2017 | 14 | Official caption revised to reflect participation of United States Patent and Trademark Office. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [443544] [CMP] [Entered: 06/30/2017 02:34 PM] (0) |
| Jun 30, 2017 | 13 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor Director - United States Patent and Trademark Office. Service: 06/30/2017 by email. [443411] [Thomas Krause] [Entered: 06/30/2017 11:14 AM] (2) |
| Jun 30, 2017 | 12 | Entry of appearance for Nathan K. Kelley as principal counsel for Intervenor Director - United States Patent and Trademark Office. Service: 06/30/2017 by email. [443409] [Nathan Kelley] [Entered: 06/30/2017 11:11 AM] (2) |
| Jun 30, 2017 | 11 | Entry of appearance for Sarah E. Craven as of counsel for Intervenor Director - United States Patent and Trademark Office. Service: 06/30/2017 by email. [443403] [Sarah Craven] [Entered: 06/30/2017 11:07 AM] (2) |
| Jun 30, 2017 | 10 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 06/30/2017 by email. [443398] [Sarah Craven] [Entered: 06/30/2017 11:05 AM] (3) |
| Jun 5, 2017 | 9 | Certified list from the United States Patent and Trademark Office. Service: 06/05/2017 by email. Appellant/Petitioner's brief is due 08/04/2017. [436389] [JB] [Entered: 06/05/2017 03:10 PM] (49) |
| May 31, 2017 | 8 | ORDER filed. The caption is revised to remove Coalition for Affordable Drugs X LLC. The revised official caption and short caption are reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days from the date of this order whether she wishes to intervene in this appeal. If the Director elects to participate as intervenor, her brief shall be due no later than 40 days from the date of filing of Anacor Pharmaceuticals, Inc.’s opening brief. Anacor may file its reply brief no later than 14 days from the date of filing of the Director’s brief. If the Director elects not to participate, Anacor shall file its appendix no later than 10 days from the date of filing of its brief. Service: 05/31/2017 by clerk. [435443] [LMS] [Entered: 05/31/2017 03:58 PM] (2) |
| May 24, 2017 | 7 | SECOND OVERDUE NOTICE to counsel for Appellee Coalition for Affordable Drugs X LLC: The record of this case indicates that no Entry of Appearance, Certificate of Interest, or Docketing Statement have been filed. Please file documents promptly. Service as of this date by Clerk of Court. [433917] [JB] [Entered: 05/24/2017 04:19 PM] (0) |
| May 17, 2017 | 6 | OVERDUE NOTICE to counsel for Appellee Coalition for Affordable Drugs X LLC: The record of this case indicates that no Entry of Appearance, Certificate of Interest, or Docketing Statement has not been filed. Please file documents promptly. Service as of this date by Clerk of Court. [432335] [JB] [Entered: 05/17/2017 03:42 PM] (0) |
| May 9, 2017 | 5 | Certificate of Interest for the Appellant Anacor Pharmaceuticals, Inc.. Service: 05/09/2017 by email. [430039] [Michael Kennedy] [Entered: 05/09/2017 02:54 PM] (2) |
| May 9, 2017 | 4 | Docketing Statement for the Appellant Anacor Pharmaceuticals, Inc.. Service: 05/09/2017 by email. [430038] [Michael Kennedy] [Entered: 05/09/2017 02:52 PM] (3) |
| May 9, 2017 | 3 | Entry of appearance for Andrea G. Reister as of counsel for Appellant Anacor Pharmaceuticals, Inc.. Service: 05/09/2017 by email. [430034] [Michael Kennedy] [Entered: 05/09/2017 02:51 PM] (2) |
| May 9, 2017 | 2 | Entry of appearance for Michael N. Kennedy as principal counsel for Appellant Anacor Pharmaceuticals, Inc.. Service: 05/09/2017 by email. [430031] [Michael Kennedy] [Entered: 05/09/2017 02:50 PM] (2) |
| Apr 25, 2017 | 1 | Appeal docketed. Received: 04/24/2017. [426891] Entry of Appearance due 05/09/2017. Certificate of Interest is due on 05/09/2017. Docketing Statement due 05/09/2017. Certified List due on 06/05/2017. [JB] [Entered: 04/25/2017 11:55 AM] (6) |
